SpineCraft obtains regulatory clearance to market Apex in China

218
SpineCraft Apex
SpineCraft Apex

SpineCraft has received clearance from the China Food and Drug Administration (CFDA) to market its Apex spine system in territory.

The Apex System is designed for complex deformity correction as well as tumor, trauma and degenerative procedures. According to a company release, it has been used in over 15,000 surgeries worldwide since its launch.